Increased expression of MMP14 correlates with the poor prognosis of Chinese patients with gastric cancer

Gene

Volumn 563, Issue 1, 2015, Pages 29-34

  Dong, Yichen ^a   Chen, Guohua ^b   Gao, Mingming ^a   Tian, Xia ^c  

^a Laiwu People s Hospital   (China)

^b SHANDONG UNIVERSITY   (China)

^c Department of Gastrointestinal Surgery ^*  (China)

Author keywords

Gastric cancer; Immunohistochemistry; Meta analysis; MMP14; Prognosis

Indexed keywords

BIOLOGICAL MARKER; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; MMP14 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CHINESE; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STOMACH CANCER; ASIAN CONTINENTAL ANCESTRY GROUP; GENE EXPRESSION REGULATION; GENETICS; META ANALYSIS; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; REFERENCE VALUE; STOMACH TUMOR; SURVIVAL;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 14; MIDDLE AGED; PROGNOSIS; REFERENCE VALUES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 84926421048     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.03.003     Document Type: Article

References (31)

1. Akanuma N., Hoshino I., Akutsu Y., Murakami K., Isozaki Y., Maruyama T., Yusup G., Qin W., Toyozumi T., Takahashi M., Suito H., Hu X., Sekino N., Matsubara H. MicroRNA-133a regulates the mRNAs of two invadopodia-related proteins, FSCN1 and MMP14, in esophageal cancer. Br. J. Cancer 2014, 110:189-198.
2. Crispi S., Calogero R.A., Santini M., Mellone P., Vincenzi B., Citro G., Vicidomini G., Fasano S., Meccariello R., Cobellis G., Menegozzo S., Pierantoni R., Facciolo F., Baldi A., Menegozzo M. Global gene expression profiling of human pleural mesotheliomas: identification of matrix metalloproteinase 14 (MMP-14) as potential tumour target. PLoS One 2009, 4:e7016.
3. de la Pena S., Sampieri C.L., Ochoa-Lara M., Leon-Cordoba K., Remes-Troche J.M. Expression of the matrix metalloproteases 2, 14, 24, and 25 and tissue inhibitor 3 as potential molecular markers in advanced human gastric cancer. Dis. Markers 2014, 2014:285906.
4. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 2010, 127:2893-2917.
5. He L., Chu D., Li X., Zheng J., Liu S., Li J., Zhao Q., Ji G. Matrix metalloproteinase-14 is a negative prognostic marker for patients with gastric cancer. Dig. Dis. Sci. 2013, 58:1264-1270.
6. Itoh Y., Seiki M. MT1-MMP: a potent modifier of pericellular microenvironment. J. Cell. Physiol. 2006, 206:1-8.
7. Kondratiev S., Gnepp D.R., Yakirevich E., Sabo E., Annino D.J., Rebeiz E., Laver N.V. Expression and prognostic role of MMP2, MMP9, MMP13, and MMP14 matrix metalloproteinases in sinonasal and oral malignant melanomas. Hum. Pathol. 2008, 39:337-343.
8. Liu Z., Yang H., Luo W., Jiang Q., Mai C., Chen Y., Zhen Y., Yu X., Long X., Fang W. Loss of cytoplasmic KLF4 expression is correlated with the progression and poor prognosis of nasopharyngeal carcinoma. Histopathology 2013, 63:362-370.
9. Maatta M., Soini Y., Liakka A., Autio-Harmainen H. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis. Clin. Cancer Res. 2000, 6:2726-2734.
10. Massi D., Franchi A., Ketabchi S., Paglierani M., Pimpinelli N., Santucci M. Expression and prognostic significance of matrix metalloproteinases and their tissue inhibitors in primary neuroendocrine carcinoma of the skin. Hum. Pathol. 2003, 34:80-88.
11. McGowan P.M., Duffy M.J. Matrix metalloproteinase expression and outcome in patients with breast cancer: analysis of a published database. Ann. Oncol. 2008, 19:1566-1572.
12. Michael M., Babic B., Khokha R., Tsao M., Ho J., Pintilie M., Leco K., Chamberlain D., Shepherd F.A. Expression and prognostic significance of metalloproteinases and their tissue inhibitors in patients with small-cell lung cancer. J. Clin. Oncol. 1999, 17:1802-1808.
13. Munaut C., Noel A., Hougrand O., Foidart J.M., Boniver J., Deprez M. Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1-MMP, MMP-2 and MMP-9 in human glioblastomas. Int. J. Cancer 2003, 106:848-855.
14. Mylona E., Nomikos A., Magkou C., Kamberou M., Papassideri I., Keramopoulos A., Nakopoulou L. The clinicopathological and prognostic significance of membrane type 1 matrix metalloproteinase (MT1-MMP) and MMP-9 according to their localization in invasive breast carcinoma. Histopathology 2007, 50:338-347.
15. Pahwa S., Stawikowski M.J., Fields G.B. Monitoring and inhibiting MT1-MMP during cancer initiation and progression. Cancers (Basel) 2014, 6:416-435.
16. Peng C.W., Wang L.W., Fang M., Yang G.F., Li Y., Pang D.W. Combined features based on MT1-MMP expression, CD11b+ immunocytes density and LNR predict clinical outcomes of gastric cancer. J. Transl. Med. 2013, 11:153.
17. Sagara Y., Miyata Y., Iwata T., Kanda S., Hayashi T., Sakai H., Kanetake H. Clinical significance and prognostic value of S100A4 and matrix metalloproteinase-14 in patients with organ-confined bladder cancer. Exp. Ther. Med. 2010, 1:27-31.
18. Shi Y., Zhou Y. The role of surgery in the treatment of gastric cancer. J. Surg. Oncol. 2010, 101:687-692.
19. Siegel R., Ma J., Zou Z., Jemal A. Cancer statistics, 2014. CA Cancer J. Clin. 2014, 64:9-29.
20. Strongin A.Y. Proteolytic and non-proteolytic roles of membrane type-1 matrix metalloproteinase in malignancy. Biochim. Biophys. Acta 2010, 1803:133-141.
21. Tetu B., Brisson J., Wang C.S., Lapointe H., Beaudry G., Blanchette C., Trudel D. The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis. Breast Cancer Res. 2006, 8:R28.
22. Trudel D., Desmeules P., Turcotte S., Plante M., Gregoire J., Renaud M.C., Orain M., Bairati I., Tetu B. Visual and automated assessment of matrix metalloproteinase-14 tissue expression for the evaluation of ovarian cancer prognosis. Mod. Pathol. 2014, 27:1394-1404.
23. Uchibori M., Nishida Y., Nagasaka T., Yamada Y., Nakanishi K., Ishiguro N. Increased expression of membrane-type matrix metalloproteinase-1 is correlated with poor prognosis in patients with osteosarcoma. Int. J. Oncol. 2006, 28:33-42.
24. Udayakumar T.S., Chen M.L., Bair E.L., Von Bredow D.C., Cress A.E., Nagle R.B., Bowden G.T. Membrane type-1-matrix metalloproteinase expressed by prostate carcinoma cells cleaves human laminin-5 beta3 chain and induces cell migration. Cancer Res. 2003, 63:2292-2299.
25. Wang L., Zhang J., Yang X., Chang Y.W., Qi M., Zhou Z., Zhang J., Han B. SOX4 is associated with poor prognosis in prostate cancer and promotes epithelial-mesenchymal transition in vitro. Prostate Cancer Prostatic Dis. 2013, 16:301-307.
26. Wang Y.Z., Wu K.P., Wu A.B., Yang Z.C., Li J.M., Mo Y.L., Xu M., Wu B., Yang Z.X. MMP-14 overexpression correlates with poor prognosis in non-small cell lung cancer. Tumour Biol. 2014, 35(10):9815-9821.
27. Wu K.P., Li Q., Lin F.X., Li J., Wu L.M., Li W., Yang Q.Z. MT1-MMP is not a good prognosticator of cancer survival: evidence from 11 studies. Tumour Biol. 2014, 35(12):12489-12495.
28. Yang B., Gao J., Rao Z., Shen Q. Clinicopathological and prognostic significance of alpha5beta1-integrin and MMP-14 expressions in colorectal cancer. Neoplasma 2013, 60:254-261.
29. Yoshizaki T., Maruyama Y., Sato H., Furukawa M. Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma. Int. J. Cancer 2001, 95:44-50.
30. Zarrabi K., Dufour A., Li J., Kuscu C., Pulkoski-Gross A., Zhi J., Hu Y., Sampson N.S., Zucker S., Cao J. Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration. J. Biol. Chem. 2011, 286:33167-33177.
31. Zhou H., Wu A., Fu W., Lv Z., Zhang Z. Significance of semaphorin-3A and MMP-14 protein expression in non-small cell lung cancer. Oncol. Lett. 2014, 7:1395-1400.